Reduction and pH dual-sensitive nanovesicles co-delivering doxorubicin and gefitinib for effective tumor therapy

Owing to the complexity of tumorgenesis, combination therapy has proven to be a viable strategy for cancer treatment in recent years. However, the delivery and site-specific release of different therapeutic agents remain a major challenge in combination therapy. In this study, a polymeric nanovesicl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yangui, Li, Xiaoxia, Xiao, Hong, Xiao, Jinpeng, Li, Bo, Chen, Xiaoyan, Wang, Yong, Cheng, Du, Shuai, Xintao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2018
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077202/
https://www.ncbi.nlm.nih.gov/pubmed/35542607
http://dx.doi.org/10.1039/c7ra12620d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077202/
https://www.ncbi.nlm.nih.gov/pubmed/35542607
http://dx.doi.org/10.1039/c7ra12620d

Ejemplares similares